-

Medable to Present at Jefferies Global Healthcare Conference

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading evidence-generation platform provider for modern clinical trials, today announced that Medable Co-founder and CEO Michelle Longmire will present at the Jefferies Global Healthcare Conference. The live presentation will take place on Thursday, June 6, 2024, at 3:30p.m. ET in New York City, New York.

The Management Team will also be available for 1:1 investor meetings at the conference. Please reach out to your Jefferies representative to schedule.

For more information, please contact:
Burak Over
SVP, Corporate Development & Investor Relations
burak@medable.com

To learn more about Medable, visit medable.com.

About Medable

Medable is on a mission to get effective therapies to people faster. Its digital clinical trials platform enhances speed, scale, and patient access in clinical research, accelerating medicines for thousands of conditions without treatment or cure. Named a Leader in the industry by Everest Group and awarded Best Digital Health Solution by the Galien Foundation, the Medable platform has been deployed in more than 300 trials in 60 countries and 120 languages, serving more than one million patients globally. Medable is a privately held, venture-backed company headquartered in Palo Alto, California, and ranked #398 on the Inc. 5000 in 2023.

Contacts

Lisa Barbadora, Barbadora INK for Medable
+1 (610) 420-3413
lbarbadora@barbadoraink.com / media@medable.com

Industry:

Medable Inc.

Details
Headquarters: Palo Alto, California
CEO: Michelle Longmire
Employees: 350
Organization: PRI
Release Versions
English

Contacts

Lisa Barbadora, Barbadora INK for Medable
+1 (610) 420-3413
lbarbadora@barbadoraink.com / media@medable.com

Social Media Profiles
Medable on LinkedIn
More News From Medable Inc.

Medable Launches Innovation Evidence Workshop – First Collaboration To Bring Leaders Together on DCT Impact, Adoption, and Best Practices

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable, the leading provider of AI-powered clinical trial technology, today announced its Innovation Evidence Workshop series, developed in collaboration with and facilitated by the Tufts Center for the Study of Drug Development (Tufts CSDD). Leaders from 20 pharmaceutical, biotech, and contract research organizations (CROs) participated in the inaugural invitation-only workshop held on November 19 in Boston, MA. Programming featured representatives from the...

Medable Named a Leader Amid Growing eCOA Adoption

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., a leading provider of clinical trial technology, today announced it has been named a Leader in Everest Group’s 2025 "Life Sciences Electronic Clinical Outcome Assessment (eCOA) Products PEAK Matrix® Assessment." Medable was recognized among 19 vendors for its strong performance across three key areas: buyer priorities, innovation, and future focus. Medable was named a Leader for its continued investment in AI and machine learning to enhance plat...

Medable to Present at Morgan Stanley Global Healthcare Conference

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., a leading AI technology platform provider for clinical research, today announced that Medable CEO and Co-Founder Michelle Longmire will be presenting a corporate update at the Morgan Stanley Global Healthcare Conference in New York City. The presentation will take place on Tuesday, September 9th 7:45 AM Eastern Time. About Medable Medable, a Software as a Service (SaaS) cloud platform, is revolutionizing clinical drug development. Our AI-driven...
Back to Newsroom